The 2023 medical landscape witnessed remarkable advancements. E1 Ventures explores the most significant ones in its 2023 report on breakthroughs in medicine.
A record 69 new drugs were FDA approved, with a focus on rare diseases and innovative mechanisms. Obesity and type 2 diabetes treatments saw a revolution with drugs like semaglutide, showing significant weight reduction and cardiovascular benefits. Alzheimer’s disease saw new drugs like lecanemab, marking modest but notable progress. Advances in gene and cell therapy included CRISPR/Cas9-based treatments for sickle cell disorders. Additionally, progress in artificial embryos and a unique method of controlling cells with electricity showcased the year’s cutting-edge scientific achievements.